» » Genome And Proteome In Oncology

Free eBook Genome And Proteome In Oncology download

by Fotini Tzortzatou Stathopoulou

Free eBook Genome And Proteome In Oncology download ISBN: 1594542856
Author: Fotini Tzortzatou Stathopoulou
Publisher: Nova Science Pub Inc (March 30, 2005)
Language: English
Pages: 360
Category: Engineering & Transportation
Subcategory: Engineering
Size MP3: 1772 mb
Size FLAC: 1136 mb
Rating: 4.6
Format: docx azw docx lrf


The nature of cancer disease, its probable causes, and the molecular and cellular mechanisms through which malignant tumours develop, have only recently begun to be understood in any appreciable detail.

by Fotini Tzortzatou Stathopoulou. See a Problem? We’d love your help.

Athanasios Papakyriakou, Dionisios Vourloumis, Fotini lou, Michael Karpusas. The current study evaluated the differential expression detected in the proteomic profiles of low risk- and high risk- ALL pediatric patients to characterize candidate biomarkers related t. More). The nature of cancer disease, its probable causes, and the molecular and cellular mechanisms through which malignant tumours develop, have only recently begun to be understood in any appreciable detail.

Hematology-Oncology Unit, First Department of Pediatrics, University of Athens, and Department of Biochemistry, Agia Sophia Children's Hospital, Athens, Greece.

Are you Fotini lou? Register this Author. Register with ORCID iD. PUBLICATIONS 39. Fotini lou. About publications (39) network. Are you Fotini lou? Register this Author. Hematology-Oncology Unit, First Department of Pediatrics, University of Athens, and Department of Biochemistry, Agia Sophia Children's Hospital, Athens, Greece. Download full-text PDF.

Cite this publication. Mangalathu S Rajeevan. We examined a panel of 26 melanoma and fibroblast samples (tissues and cultured cells) to evaluate the suitability of two commonly used housekeeping genes, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and 18S ribosomal RNA (rRNA), for quantitative real-time PCR. Both genes showed significant variations within the individual cell line and tissue groups.

The Atlas of Genetics and Cytogenetics in Oncology and Haematology, created in 1997 by Jean-Loup Huret (with bioinformatics by Philippe Dessen) is a collection of resources on genes, chromosomes anomalies, leukemias, solid tumours, and cancer-prone . .

The Atlas of Genetics and Cytogenetics in Oncology and Haematology, created in 1997 by Jean-Loup Huret (with bioinformatics by Philippe Dessen) is a collection of resources on genes, chromosomes anomalies, leukemias, solid tumours, and cancer-prone diseases.

Differential proteomic analysis was performed by two-dimensional gel electrophoresis and protein identification by matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry.

Athanasios K. Anagnostopoulos. Chrisa Papathanassiou. Differential proteomic analysis was performed by two-dimensional gel electrophoresis and protein identification by matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry. No significant correlations were noted between protein patterns and cytogenetic or molecular analyses. Certain suppressor genes, metabolic enzymes, immunoglobulins and actin-binding proteins were differentially expressed by BM or PB plasma and cell lysates compared to controls.

In the present study, a series of proteomics, genomics, and bioinformatics approaches were employed to identify, classify and characterize the proteome content of low-grade brain tumors as it appears in early childhood.

J Proteome Res. 2011 May 6;10(5):2555-65. doi: 1. 021/pr200024m. In the present study, a series of proteomics, genomics, and bioinformatics approaches were employed to identify, classify and characterize the proteome content of low-grade brain tumors as it appears in early childhood. Through bioinformatics database construction, protein profiles generated from pathological tissue samples were compared against profiles of normal brain tissues. Additionally, experiments of comparative genomic hybridization arrays were employed to monitor for genetic aberrations and sustain the interpretation and evaluation of the proteomic data.

Fotini Tzortzatou Stathopoulou. Genome and proteome in oncology Close. Are you sure you want to remove Genome and proteome in oncology from your list? Genome and proteome in oncology. Published 2005 by Nova Science Publishers in New York.

The nature of cancer disease, its probable causes, and the molecular and cellular mechanisms through which malignant tumours develop, have only recently begun to be understood in any appreciable detail. Cancer is fundamentally a disease of the genome, arising from dynamic changes occurring within DNA during the lifetime of the cell e.g. deletions, amplifications, point mutations, translocations that can occur in any cell and that may interact in a variety of cellular pathways. The imbalance in the interplay between genetic and environmental factors can initiate malignancy. The determination of the human genome sequence is acclaimed as one of the great achievements made possible by the rapid progress in the available molecular biology tools achieved during the last few years. The sequence of the human genome promises to unveil invaluable information useful for the development of novel approaches in the diagnosis and treatment of cancer disease. This book includes part of the work of international experts on the most up-to-date developments of various aspects of research on genome and proteome in oncology. the number of genes but in how gene parts are used to build different products in a process of the mRNA transcript called alternative splicing.